CAS: 1303420-67-8
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | PLX5622 REF: TM-T7100CAS: 1303420-67-8 | 98% - 99.89% | 93,00 €~1.311,00 € | Do 03 Apr 25 |
 | PLX5622 REF: 3D-DCC42067CAS: 1303420-67-8 | Min. 95% | 336,00 €~2.059,00 € | Do 08 Mai 25 |
 | 6-Fluoro-N-((5-fluoro-2-methoxypyridin-3-yl)methyl)-5-((5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)pyridin-2-amine REF: 10-F546450CAS: 1303420-67-8 | 97.0% | - - - | Ausgelaufenes produkt |
PLX5622
CAS:1303420-67-8
PLX5622 is a selective, orally active and blood-brain barrier permeable CSF1R inhibitor. PLX5622 induces elimination …
Formel:
C21H19F2N5O
Reinheit:
98% - 99.89%
Farbe und Form:
Solid
Molekulargewicht:
395.41
Ref: TM-T7100
| 5mg | 96,00 € | ||
| 10mg | 158,00 € | ||
| 25mg | 308,00 € | ||
| 50mg | 510,00 € | ||
| 100mg | 617,00 € | ||
| 500mg | 1.311,00 € | ||
| 1mL*10mM (DMSO) | 94,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 3. April 2025
PLX5622
CAS:1303420-67-8
PLX5622 is a small molecule that binds to the integrin receptor, which is a calcium-binding …
Formel:
C21H19F2N5O
Reinheit:
Min. 95%
Molekulargewicht:
395.41 g/mol
Ref: 3D-DCC42067
| 5mg | 336,00 € | ||
| 10mg | 479,00 € | ||
| 25mg | 855,00 € | ||
| 50mg | 1.288,00 € | ||
| 100mg | 2.059,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 8. Mai 2025
![6-Fluoro-N-((5-fluoro-2-methoxypyridin-3-yl)methyl)-5-((5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)met…](https://static.cymitquimica.com/products/10/thumb/F546450.jpg)
6-Fluoro-N-((5-fluoro-2-methoxypyridin-3-yl)methyl)-5-((5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)pyridin-2-amine
CAS:1303420-67-8
Reinheit:
97.0%
Molekulargewicht:
395.41400146484375
Ref: 10-F546450
| 250mg | Ausgelaufen | Anforderung von Informationen |
